These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38933712)

  • 1. Prolactin-activated PAK1 potentiates estrogen response to breast cancer cell epithelial-mesenchymal transition, migration and invasion.
    Hammer A; Diakonova M
    MicroPubl Biol; 2024; 2024():. PubMed ID: 38933712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
    Hammer A; Diakonova M
    BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.
    Hammer A; Diakonova M
    Adv Exp Med Biol; 2015; 846():97-137. PubMed ID: 25472536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.
    Rider L; Oladimeji P; Diakonova M
    Mol Endocrinol; 2013 Jul; 27(7):1048-64. PubMed ID: 23744893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAK1 translocates into nucleus in response to prolactin but not to estrogen.
    Oladimeji P; Diakonova M
    Biochem Biophys Res Commun; 2016 Apr; 473(1):206-211. PubMed ID: 27003261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1.
    Oladimeji P; Skerl R; Rusch C; Diakonova M
    Cancer Res; 2016 May; 76(9):2600-11. PubMed ID: 26944939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin A.
    Hammer A; Rider L; Oladimeji P; Cook L; Li Q; Mattingly RR; Diakonova M
    Mol Endocrinol; 2013 Mar; 27(3):455-65. PubMed ID: 23340249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin-induced tyrosyl phosphorylation of PAK1 facilitates epithelial-mesenchymal transition.
    Hammer A; Diakonova M
    MicroPubl Biol; 2024; 2024():. PubMed ID: 38660565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.
    Tao J; Oladimeji P; Rider L; Diakonova M
    Mol Endocrinol; 2011 Sep; 25(9):1565-78. PubMed ID: 21719533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
    Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
    PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of protein kinase PAK1 in the regulation of estrogen-independent growth of breast cancer].
    Avilova EA; Andreeva OE; Shatskaia VA; Krasil'nikov MA
    Biomed Khim; 2014; 60(3):322-31. PubMed ID: 25019394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src tyrosyl phosphorylates cortactin in response to prolactin.
    Hammer A; Laghate S; Diakonova M
    Biochem Biophys Res Commun; 2015 Aug; 463(4):644-9. PubMed ID: 26043691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells.
    Vadlamudi RK; Adam L; Wang RA; Mandal M; Nguyen D; Sahin A; Chernoff J; Hung MC; Kumar R
    J Biol Chem; 2000 Nov; 275(46):36238-44. PubMed ID: 10945974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the PRL-PAK1 Pathway in Cancer Cell Migration.
    Carrasco-Ceballos JM; Barrera-Hernández D; Locia-Espinosa J; Sampieri CL; Lara-Reyes JA; Hernández-Aguilar ME; Aranda-Abreu GE; Toledo-Cárdenas MR; Chi-Castañeda LD; Pérez-Estudillo CA; Rojas-Durán F
    Cancer Diagn Progn; 2023; 3(1):17-25. PubMed ID: 36632591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1.
    Adam L; Vadlamudi R; Mandal M; Chernoff J; Kumar R
    J Biol Chem; 2000 Apr; 275(16):12041-50. PubMed ID: 10766836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Derivative of Differentiation-Inducing Factor-3 Inhibits PAK1 Activity and Breast Cancer Cell Proliferation.
    Oladimeji P; Kubohara Y; Kikuchi H; Oshima Y; Rusch C; Skerl R; Diakonova M
    Int J Cancer Clin Res; 2015; 2(3):1-6. PubMed ID: 26688830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.
    Rayala SK; Kumar R
    Biomed Pharmacother; 2007 Aug; 61(7):408-11. PubMed ID: 17604944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover.
    Hammer A; Oladimeji P; De Las Casas LE; Diakonova M
    FASEB J; 2015 Mar; 29(3):943-59. PubMed ID: 25466889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
    Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E
    Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.
    Huynh N; Liu KH; Baldwin GS; He H
    Biochim Biophys Acta; 2010 Sep; 1803(9):1106-13. PubMed ID: 20595063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.